Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 550

1.

Refinement of breast cancer classification by molecular characterization of histological special types.

Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF, de Jong D, Van de Vijver MJ, Van't Veer LJ, Peterse JL.

J Pathol. 2008 Oct;216(2):141-50. doi: 10.1002/path.2407.

PMID:
18720457
2.

Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type.

Weigelt B, Geyer FC, Horlings HM, Kreike B, Halfwerk H, Reis-Filho JS.

Mod Pathol. 2009 Nov;22(11):1401-14. doi: 10.1038/modpathol.2009.112. Epub 2009 Jul 24.

3.

Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype-matched ductal and lobular carcinomas.

Lopez-Garcia MA, Geyer FC, Natrajan R, Kreike B, Mackay A, Grigoriadis A, Reis-Filho JS, Weigelt B.

J Pathol. 2010 Sep;222(1):64-75. doi: 10.1002/path.2743.

PMID:
20593406
4.

Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.

Lacroix-Triki M, Suarez PH, MacKay A, Lambros MB, Natrajan R, Savage K, Geyer FC, Weigelt B, Ashworth A, Reis-Filho JS.

J Pathol. 2010 Nov;222(3):282-98. doi: 10.1002/path.2763.

PMID:
20815046
5.

The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.

Weigelt B, Geyer FC, Natrajan R, Lopez-Garcia MA, Ahmad AS, Savage K, Kreike B, Reis-Filho JS.

J Pathol. 2010 Jan;220(1):45-57. doi: 10.1002/path.2629.

PMID:
19877120
6.

Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas.

Simpson PT, Reis-Filho JS, Lambros MB, Jones C, Steele D, Mackay A, Iravani M, Fenwick K, Dexter T, Jones A, Reid L, Da Silva L, Shin SJ, Hardisson D, Ashworth A, Schmitt FC, Palacios J, Lakhani SR.

J Pathol. 2008 Jul;215(3):231-44. doi: 10.1002/path.2358.

PMID:
18473330
7.

Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

Thorat MA, Marchio C, Morimiya A, Savage K, Nakshatri H, Reis-Filho JS, Badve S.

J Clin Pathol. 2008 Mar;61(3):327-32. Epub 2007 Nov 23.

PMID:
18037662
8.

The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics.

Nagao T, Kinoshita T, Hojo T, Tsuda H, Tamura K, Fujiwara Y.

Breast. 2012 Jun;21(3):289-95. doi: 10.1016/j.breast.2011.12.011. Epub 2012 Jan 25.

PMID:
22277312
9.

Breast cancer special types: why bother?

Reis-Filho JS, Lakhani SR.

J Pathol. 2008 Dec;216(4):394-8. doi: 10.1002/path.2419.

PMID:
18798222
10.

Classification of ductal carcinoma in situ by gene expression profiling.

Hannemann J, Velds A, Halfwerk JB, Kreike B, Peterse JL, van de Vijver MJ.

Breast Cancer Res. 2006;8(5):R61.

11.

Comparative expressed sequence hybridization reveals differential gene expression in morphological breast cancer subtypes.

Vanden Bempt I, Vanhentenrijk V, Drijkoningen M, De Wolf-Peeters C.

J Pathol. 2006 Mar;208(4):486-94.

PMID:
16402338
12.

Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis.

Weigelt B, Kreike B, Reis-Filho JS.

Breast Cancer Res Treat. 2009 Sep;117(2):273-80. doi: 10.1007/s10549-008-0197-9. Epub 2008 Sep 25.

PMID:
18815879
13.

15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma.

Celis JE, Gromov P, Cabezón T, Moreira JM, Friis E, Jirström K, Llombart-Bosch A, Timmermans-Wielenga V, Rank F, Gromova I.

Mol Cell Proteomics. 2008 Oct;7(10):1795-809. doi: 10.1074/mcp.R800011-MCP200. Epub 2008 Jul 16.

14.

[Prognostic molecular classification of breast cancers based on gene expression profiling].

Feng YM, Li XQ, Sun BC, Gao XC, Gu L, Niu Y, Hao XS.

Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):900-6. Chinese.

PMID:
17533740
15.

A resampling-based meta-analysis for detection of differential gene expression in breast cancer.

Gur-Dedeoglu B, Konu O, Kir S, Ozturk AR, Bozkurt B, Ergul G, Yulug IG.

BMC Cancer. 2008 Dec 30;8:396. doi: 10.1186/1471-2407-8-396.

16.

Prognostic significance of molecular classification of breast invasive ductal carcinoma.

Muñoz M, Fernández-Aceñero MJ, Martín S, Schneider J.

Arch Gynecol Obstet. 2009 Jul;280(1):43-8. doi: 10.1007/s00404-008-0867-1. Epub 2008 Dec 11.

PMID:
19082617
17.

Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study.

Rodríguez-Pinilla SM, Rodríguez-Gil Y, Moreno-Bueno G, Sarrió D, Martín-Guijarro Mdel C, Hernandez L, Palacios J.

Am J Surg Pathol. 2007 Apr;31(4):501-8.

PMID:
17414096
18.

Reappraisal of immunohistochemical profiling of special histological types of breast carcinomas: a study of 121 cases of eight different subtypes.

Alvarenga CA, Paravidino PI, Alvarenga M, Gomes M, Dufloth R, Zeferino LC, Vassallo J, Schmitt FC.

J Clin Pathol. 2012 Dec;65(12):1066-71. doi: 10.1136/jclinpath-2012-200885. Epub 2012 Sep 3.

PMID:
22944625
19.

Fine-needle aspiration cytologic features of four special types of breast cancers: mucinous, medullary, apocrine, and papillary.

Haji BE, Das DK, Al-Ayadhy B, Pathan SK, George SG, Mallik MK, Abdeen SM.

Diagn Cytopathol. 2007 Jul;35(7):408-16.

PMID:
17580344
20.

Genomic profiling of histological special types of breast cancer.

Horlings HM, Weigelt B, Anderson EM, Lambros MB, Mackay A, Natrajan R, Ng CK, Geyer FC, van de Vijver MJ, Reis-Filho JS.

Breast Cancer Res Treat. 2013 Nov;142(2):257-69. doi: 10.1007/s10549-013-2740-6. Epub 2013 Oct 27.

PMID:
24162157

Supplemental Content

Support Center